Progress in MS Research Live Update 2020

Watch our Progress in MS Research Live Update 2020 to hear from MS experts on the latest research. Joining us this year are speakers Associate Professor Kaylene Young, Associate Professor Todd Hardy, and Dr Yvonne Learmonth, and hosts Dr Julia Morahan and Breony Heanue.

ofatumumab autoinjector pen

A reminder about PBS listing changes for REBIF and AVONEX

REBIF (interferon beta-1a) and AVONEX (interferon beta-1a) are currently used for the treatment of Australians living with relapsing forms of MS. Recently, there were some changes announced to their listing on the PBS.

Changes announced to AVONEX listing on PBS

From 1 April 2023, AVONEX will no longer be available on the Pharmaceutical Benefits Scheme (PBS) for Australians living with MS.

What us to keep you in the loop? Subscribe today!

  • Enter your details

Read More
InforMSRohan Greenland CEO MS Australia

Newsletter subscription

  • Enter your details

Progress in MS Research Live Update 2020